OTC Stocks Mixed: ZERO, ALAN, CTIX, PGSI, PVCT

Pompano Beach, FL -- (SBWIRE) -- 10/16/2012 -- Save the World Air Inc(OTC:ZERO) fell 6.10% to $1.54 on over 924K shares. Save the World Air, Inc. (STWA) is a development-stage company. The Company designs, licenses and develops products to improve energy efficiency of energy production and improve diesel engine performance. The Company has two product lines: Applied Oil Technology (AOT) and ELEKTRA.

Will ZERO Continue to Fall? Get Our Special Report To Get complete technical analysis on ZERO go click my link

Alanco Technologies, Inc. (OTC:ALAN) went up 2.96% to $0.700. Alanco Technologies, Inc. (Alanco) is a provider of information technology solutions. Its business operations focus is providing wireless monitoring and asset management solutions through its StarTrak Systems, LLC (StarTrak) subsidiary.

To Get complete technical analysis on ALAN go click my link

Cellceutix Corp (OTC:CTIX) gained 4.40% to $0.950. Cellceutix Corporation is an early-stage developmental biopharmaceutical company. The Company has acquired exclusive rights to eight different pharmaceutical compound candidates that are designed for treatment of diseases which exist, or may exist in the future.

Get Free Trend Analysis on CTIX go click my link

Pegasi Energy Resources Corp (OTC:PGSI) went up 8.33% to $0.650. Pegasi Energy Resources Corporation (Pegasi) is an independent energy company engaged in the exploration for and production of crude oils and natural gas. The Company's focus is on the development of a high-potential project in the active East Texas oil and gas region.

Will PGSI Continue to Jump? Get Our Special Report To Get complete technical analysis on PGSI go click my link

Provectus Pharmaceuticals, Inc. (OTC:PVCT) lost 3.33% to $0.580. Provectus Pharmaceuticals, Inc. is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications. The Company develops and focuses to license or market and sells its two prescription drug candidates, PV-10 and PH-10.

To Get complete technical analysis on PVCT go click my link

About Csrnewsdaily.com
Csrnewsdaily.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.

Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.

Disclaimer:
The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.

Contact:
Csrnewsdaily.com
info@csrnewsdaily.com